Description:
XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV
POLYMERASE, DNA, ETA; POLH
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Nucleotide and Nucleic Acid Metabolism |
Class |
Repair Defective and Chromosomal Instability Syndromes |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Ethnicity
|
TURKISH
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
1 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
POLH |
Chromosomal Location |
6p21.1-p12 |
Allelic Variant 1 |
; XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV |
Identified Mutation |
c.454C>T (p.Gln152Ter) |
|
Gene |
POLH |
Chromosomal Location |
6p21.1-p12 |
Allelic Variant 2 |
; XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV |
Identified Mutation |
c.454C>T (p.Gln152Ter) |
Remarks |
XP70TMA; Turkish; clinically affected; squamous and basal cell carcinomsa; affected brother is GM14875; see GM15698 Lymphoblast; skin legions onset at age 4 yrs; telangiectasias; actinic keratosis; freckles; hypopigmentation; consanguinity; normal unscheduled DNA synthesis |
Passage Frozen |
1 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|